Immutep Limited (IMMP)

Trade IMMP now with
9/17/2020 8:47:44 PM Immutep Announces Improving Results From Stage I Of Phase II TACTI-002 Study
5/28/2020 9:00:56 PM Immutep Gets US$2.4 Mln R&D Tax Incentive From French Government
4/28/2020 8:07:38 AM Immutep Announces Further Positive Interim Data From Phase II TACTI-002 Study
3/9/2020 8:11:37 AM Immutep Gets Second IND Approval For Efti From US FDA
10/10/2019 8:06:50 AM Immutep Secures A$2.5 Mln R&D Tax Incentive From French Government
9/17/2019 8:09:20 AM Immutep Secures Japanese Patent Grant For LAG525 Antibody
6/21/2019 8:09:44 AM Immutep Secures Australian Patent For Eftilagimod Alpha In Chemo-Immunotherapy
9/27/2018 4:42:00 AM Immutep Enters Agreement With Merck/Pfizer To Investigate Combination Of APC Activator Efti With Avelumab
9/24/2018 8:15:06 AM Immutep Enters Into Clinical Trial Collaboration And Supply Agreement With Merck KGaA And Pfizer
8/21/2018 4:48:53 AM Immutep Receives A$1.9 Mln Research And Development Related Tax Rebate From French Government
7/30/2018 10:32:04 PM Immutep’s LAG-3 Immunostimulant Product Candidate, Efti, Receives IND Approval From U.S. FDA